Patrick Pj Phillips

34PUBLICATIONS
115CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)MycologySociolinguisticsRegenerative medicine (incl. stem cells)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Mar 13, 2026
When are uncontrolled trials in TB scientifically and ethically justified: Borrowing wisdom from early AIDS clinical trials.

Lindsay McKenna, Mike Frick, Valentina A Alarcón-Guizado

|Jan 21, 2026
Evaluating the Cepheid Xpert TB/LTBI research-use-only assay for detection of active and latent Mycobacterium tuberculosis infection.

Brittney Sweetser, Hoang Nguyen, Hai Dang

|Jul 30, 2025
Reply to Liao <i>et al.</i>: Optimizing Levofloxacin Dosing for Multidrug-resistant Tuberculosis in Low-Fat-Free Mass Asian Populations.

Patrick P J Phillips, Charles A Peloquin, Timothy R Sterling

|May 13, 2025
Author Correction: Risk-stratified treatment for drug-susceptible pulmonary tuberculosis.

Vincent K Chang, Marjorie Z Imperial, Patrick P J Phillips

|Mar 13, 2025
Efficacy and Safety of Higher Doses of Levofloxacin for Multidrug-resistant Tuberculosis: A Randomized, Placebo-controlled Phase II Clinical Trial.

Patrick P J Phillips, Charles A Peloquin, Timothy R Sterling

|Dec 06, 2024
C-Reactive Protein-based Screening of People with Tuberculosis Symptoms: A Diagnostic Accuracy Study.

Brigitta Derendinger, Tessa K Mochizuki, Danaida Marcelo

Pageof 6